Difficulties in studying myocardial metabolism with adequate time resolution have led to contradictory conclusions regarding the mechanisms causing contractile abnormalities during the early stages of ischemia. In acutely instrumented swine, we investigated whether abnormalities in subendocardial ATP, phosphocreatine, or lactate content develop rapidly enough during the first few heart beats after onset of partial myocardial ischemia to contribute to contractile failure. Within the first 15 beats of a 40-50%o reduction in left anterior descending coronary artery blood flow, regional myocardial function was significantly reduced but continuing to deteriorate. Rapidly frozen transmural left ventricular biopsies obtained on the 15th heart beat (±1.5 beats) after the onset of ischemia revealed significant decrements in subendocardial phosphocreatine and ATP levels to 77% (p <0.05) and 84% (p <0. tion. Our pilot studies indicated that measurable changes in regional myocardial function occur within the first few heart beats of ischemia. We used rapidfreezing biopsy techniques that could be timed to a given heart beat after the onset of ischemia. Since some reported nuclear magnetic resonance measurements suggested that metabolite contents change too slowly to account for a change in myocardial function, it seemed likely that we would not detect any significant change in ATP or PCr by the 15th heart beat of ischemia (-10 seconds). To minimize the chances of a type II statistical error, these experiments were designed to have high statistical power to detect a change in these particular metabolites on this time scale. Our experimental design provides the strictest challenge to dissociate myocardial dysfunction from metabolic changes in that the degree of blood flow reduction was less severe and of shorter duration than it was in any prior study of early ischemia. The surgical preparation used in these protocols was similar to that previously reported.5,6 A short section of the proximal left anterior descending coronary artery (LAD) was dissected free to allow placement of an electromagnetic flow probe and a hydraulic occluder around the artery with no arterial branches between these devices. Catheters were placed in the distal LAD to monitor LAD perfusion pressure, in the interventricular vein parallel to the LAD for obtaining blood samples, in the left atrium for microsphere injection, in the aorta for reference blood samples, and in the inferior vena cava for fluids and supplemental anesthesia. A catheter-tipped manometer was introduced into the left ventricular (LV) apex to monitor LV pressure and LV dP/dt. Finally, ischemic zone function was monitored by continuously measuring systolic wall thickness between an ultrasonic crystal inserted into the subendocardium and one sutured to the epicardial surface.7,8 With this preparation, blood flow through the LAD could be reduced to a preselected fraction of control and maintained at that level throughout the remainder of the experiment.
M yocardial function deteriorates rapidly after the sudden onset of ischemia or hypoxia. Allen and Orchard' have reviewed many of the potential mechanisms leading to this decline in myocardial function. The factors most likely to cause contractile failure can be divided into three major categories: 1) metabolic factors, which encompass alterations in cellular energetics and accumulation of degradation products such as inorganic phosphate (Pi) or hydrogen ions; 2) activation factors, including shortening of the action potential duration, which would reduce systolic calcium release; and 3) mechanical factors, such as perfusion pressure, which might decrease systolic function as mediated through changing myocardial distension (preload) or conceivably by other vascularmyocardial coupling mechanisms. All of these variables could lead to abnormal myocardial function during the early phase of ischemia, but the relative importance of each mechanism in vivo is less well understood. Several investigators have tried to assess this latter question by examining whether or not a given parameter changes rapidly enough during ischemia to cause contractile failure. [2] [3] [4] This approach assumes that any metabolic factor that changes at a rate slower than the change in myocardial function is unlikely to have a substantial causal role.
Three elegant studies using nuclear magnetic resonance spectroscopic techniques optimized to tion. Our pilot studies indicated that measurable changes in regional myocardial function occur within the first few heart beats of ischemia. We used rapidfreezing biopsy techniques that could be timed to a given heart beat after the onset of ischemia. Since some reported nuclear magnetic resonance measurements suggested that metabolite contents change too slowly to account for a change in myocardial function, it seemed likely that we would not detect any significant change in ATP or PCr by the 15th heart beat of ischemia (-10 seconds). To minimize the chances of a type II statistical error, these experiments were designed to have high statistical power to detect a change in these particular metabolites on this time scale. Our experimental design provides the strictest challenge to dissociate myocardial dysfunction from metabolic changes in that the degree of blood flow reduction was less severe and of shorter duration than it was in any prior study of early ischemia. 
Materials and Methods

Experimental Protocol
The actual experiment began with a complete set of control data. These data included resting hemodynamics ( Figure 1 ), arteriovenous blood samples across the LAD perfusion zone, the first transmyocardial LV biopsy, and injection of the first set of microspheres. After a few minutes, blood flow through the LAD was acutely reduced approximately 40-50% and was maintained at that level throughout the remainder of the experiment. The pressure, and the dichrotic notch demonstrated the fidelity of this catheter system.12 The events after an abrupt partial reduction in LAD blood flow (first dotted line) demonstrated the rapidity with which contractile abnormalities developed after the change in LAD blood flow and LAD perfusion pressure. Mean LAD blood flow was reduced by 50% but then remained stable until the first biopsy (second dotted line), which triggered the premature ventricular complex at the far right. LAD perfusion pressure distal to the occluder fell rapidly in parallel with LAD blood flow. Contractile function gradually decreased after the onset of partial ischemia as indicated by the reduced systolic LV wall thickening. The timing of end systole is critical during moderate ischemia because postsystolic thickening does not contribute to external cardiac work. When standard criteria for timing based on the electrocardiogram and LV dP/dt were used,8 systolic wall thickening fell from 38% at control to 22% by the 16th beat. The biopsy occurred on the 16th heart beat and was followed by a brief period of instability.
Radioactive microspheres injected into the left atrium helped to validate the accuracy of the electromagnetic flow probe readings of LAD blood flow as well as to assess the transmural distribution of blood flow. All electromagnetic flow probes used in these experiments have been calibrated with known flow rates of whole blood ex vivo. In addition, brief occlusions verified the zero-flow baseline before and after the experiment. Figure 2 shows Figure 3 summarizes results for the eight animals studied during a 50% reduction in LAD blood flow. The dotted lines indicate the response of each individual animal until the time of the first biopsy during ischemia (open circles). Average normalized wall thickening (±SD) for the group is shown for every third beat (dark circles with error bars). The time axis was calibrated as the number of heart beats from the onset of ischemia. Since the average heart rate was 90 beats per minute, 15 beats is equivalent to 10 seconds of ischemia. The final heart beat refers to the regional function just before the 10-minute biopsy point.
Of note in Figure 3 , regional function began to deteriorate within the first few beats of ischemia. By the 15th beat of ischemia, regional function was significantly different from control data (p<0.001). During these initial 15 beats of ischemia, about half of the reduction in wall thickening that eventually developed by 10 minutes (final) was already present. A new plateau usually occurred within 30 to 60 seconds and remained stable throughout the experiment. The precision of the timing of biopsy was borne out by the fact that all but one animal was biopsied within one heart beat of the target desired.
Other 
Metabolic Observations During Very Early Ischemia
The major question posed by this work concerns whether or not changes in subendocardial metabolite contents occur rapidly enough to contribute to the development of myocardial dysfunction after the onset of partial ischemia. Figure 4 Issues concerning the sensitivity of various techniques in terms of their ability to detect early changes in ATP or PCr content became evident here. In these experiments, transmural changes in PCr content and ATP content were not statistically significant by the time of the first biopsy. For example, transmural ATP content fell by only 8%. Thus, studies that only measure subepicardial metabolite content or transmural metabolite levels may be too insensitive to detect metabolic changes on this rapid a time scale.
If changes in ATP, PCr, or Pi contribute significantly to developing contractile abnormalities, one would expect a correlation between these parameters and regional wall thickening. Figure 6 shows the relation between regional wall thickening and subendocardial PCr content. Figure 6 . In this animal, subendocardial PCr content was normal at control, decreased to 61% of control at 15 beats of Despite anesthesia, these hearts operated within physiological ranges of heart rate, blood pressure, preload, and coronary blood flow. The degree of ischemia only moderately changed systemic hemodynamics. Consequently, the ischemic segment was stressed by normal systolic pressures. Under these conditions, the ischemic segment continued to perform external work, as evidenced by some residual systolic wall thickening. Finally, the biopsy technique assessed metabolites with a rapid time resolution (± 1.5 heart beats) and across three layers of the LV wall.
Comparison With Prior Studies
Several studies have examined the metabolic and functional events during relatively early ischemia. For a variety of reasons, most metabolic observations during early ischemia have been performed between 1 and 15 minutes after complete reductions in blood flow. Much of this work has been summarized in a review by Allen and Orchard.1
Myocardial biopsy techniques have been used to address the metabolic and functional consequences during the first 60 seconds of ischemia or anoxia. In a protocol similar to ours using a 50% reduction in LAD blood flow in dogs, Covell et al13 noted a 40% decrease in PCr but no change in ATP an average of 47 seconds into ischemia. Others noted 10-20% changes in ATP content during the first 60 seconds of ischemia, but these changes were not statistically significant.14,15 Making metabolic measurements at several time penods during the first 30 seconds of anoxia in isolated perfused rat hearts, Hearse'6 found changes in ATP and PCr content at 10 seconds similar to those we reported at 15 beats of ischemia. Hearse concluded that these meta-bolic changes actually preceded development of myocardial dysfunction. Overall, it is reasonably well accepted that PCr begins to fall in the first minute of ischemia. Although many studies have shown a trend toward 10-20% changes in ATP levels, our study appears to be the first to have the statistical power to demonstrate the change in subendocardial ATP content (or conversely exclude a change had it not been present) at such an early stage of ischemia.
Because of limitations inherent to biopsy and chemical extraction techniques, several groups have used nuclear magnetic resonance spectroscopy to assess metabolic events during the first minute of myocardial ischemia. Unfortunately seconds of ischemia as developed pressure fell to 50% of control values in isolated perfused ferret hearts. Furthermore, they found that global LV function deteriorated less rapidly after microembolization-induced ischemia. They concluded that metabolic factors did not occur rapidly enough to contribute to ischemic dysfunction but that perfusion pressure was a likely regulating force. However, the isolated perfused heart may behave quite differently from other systems described; it has been demonstrated that even much longer durations of decreased perfusion pressure do not cause the same metabolic changes expected during ischemia.18 During regional ischemia, as shown in the current study, the normal segment develops systolic pressure against which the ischemic segment must at least maintain wall stress (and thus high energy requirements). In contrast, decreasing developed systolic pressure during global LV ischemia may act to reduce myocardial oxygen requirements. This could slow the rate at which ATP and PCr are consumed.
Additionally, the conclusion that perfusion pressure modulates myocardial function does not appear to apply to the heart in situ. 19 One might speculate that the high coronary perfusate flow rates (10-20 times normal coronary blood flow rates) may invoke preload-mediated mechanisms not usually seen in vivo. Finally, the finding that microembolization caused slower development of contractile abnormalities may be explained by the uniform transmural distribution of ischemia (and thus less severe subendocardial ischemia). The importance of subendocardial vulnerability to ischemia20,21 and subendocardial segment shortening22 have previously been discussed. So although Koretsune et 
